The classification of pericardial disease in the age of modern medicine

Bernhard Maisch1, Arsen D Ristić

  • 1Department of Internal Medicine-Cardiology, Philipps University, Marburg, Baldingerstrasse 1, 35033 Marburg, Germany. BerMaisch@aol.com

Current Cardiology Reports
|December 18, 2001
PubMed

Insights

New diagnostic methods improve the classification of pericardial diseases, distinguishing viral from autoreactive pericarditis. This distinction guides targeted corticosteroid therapy, improving patient outcomes for pericardial conditions.

Area of Science:

  • Cardiology and Immunology
  • Molecular Biology and Imaging

Background:

  • Pericardial diseases encompass a range of conditions including pericarditis, neoplasms, cysts, and congenital defects.
  • Many cases were previously classified as idiopathic due to limitations in noninvasive diagnostic techniques.
  • Accurate etiological diagnosis is crucial for effective therapeutic strategies in pericardial disease management.

Purpose of the Study:

  • To enhance the classification of pericardial diseases by integrating advanced diagnostic modalities.
  • To differentiate between viral and autoreactive forms of idiopathic pericarditis.
  • To establish foundations for etiology-specific treatment of pericardial conditions.

Main Methods:

  • Synthesis of modern imaging techniques with molecular biology and immunology.
  • Systematic analysis of pericardial fluid.
  • Application of pericardioscopy, pericardial biopsy, and molecular/immunological assays.

Main Results:

  • A clear distinction is now possible between the two most frequent forms of idiopathic pericarditis: viral and autoreactive.
  • This improved classification has significant therapeutic implications.
  • New techniques enable early and specific diagnosis of pericardial diseases.

Conclusions:

  • The integration of advanced diagnostics facilitates precise classification of pericardial diseases.
  • Distinguishing between viral and autoreactive pericarditis dictates treatment, with corticosteroids beneficial in autoreactive but contraindicated in viral forms.
  • These advancements pave the way for targeted, etiology-based treatments, improving management of pericardial conditions.

Related Concept Videos

Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
Pericarditis I: Introduction01:22

Pericarditis I: Introduction

Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...